This Week in European HealthTech - Week 3 October 2025

Major developments in European HealthTech this week have been dominated by major funding rounds in biotech, significant regulatory alignment and continued investment in digital health.

Here are the key highlights:

1. Record-Breaking Funding Rounds

German Biotech Tubulis secured a €308 million Series C financing round. This is reported as the largest Series C ever raised by a European biotech and the largest private financing globally for an antibody-drug conjugate (ADC) developer. The funds will advance their cancer therapies, including a lead candidate in a Phase I/IIa study.

Finnish HealthTech Oura (the smart ring maker) raised substantial fresh funding, valuing the company at around $11 billion, and plans to accelerate AI and product innovation globally.

British investor Spex Capital announced the first €30 million commitment to its flagship €100 million Venture HealthTech Fund, aimed at global early-stage HealthTech startups.

2. Regulatory & International Cooperation

The UK's MHRA (Medicines and Healthcare products Regulatory Agency) and the US FDA (Food and Drug Administration) announced a deeper collaboration on medical technologies and AI. This alliance aims to harmonize regulation and create new reliance routes to speed up safe access to innovative devices in the UK.

The EU Data Act's obligations became applicable this week, which is a major regulatory cornerstone designed to unlock the value of data across sectors, including healthcare and life sciences, by establishing rules on data access and use.

3. Product Launches and AI Adoption
 
Medtronic launched its VitalFlow ECMO system in Europe, a new one-system platform for critical care.

Vektor Medical secured the CE mark for vMap, an AI-assisted, non-invasive arrhythmia mapping product, allowing its entry into the EU market.

There's ongoing focus on AI integration in clinical settings, with reports on major NHS trusts pushing forward with comprehensive AI strategy roadmaps.

To discuss how Nelson Advisors can help your HealthTech or MedTech company, please email [email protected]